IMVT position history
The shares of Immunovant (IMVT) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2023 Q3: 504,000 shares, $19M, 0.10% of portfolio, New
- 2023 Q4: 341,000 shares, $14M, 0.07% of portfolio, Reduce −32.3%
- 2024 Q1: not held, Exit
- 2024 Q2: 12,000 shares, $317K, <0.01% of portfolio, New
- 2024 Q3: 12,000 shares, $342K, <0.01% of portfolio
- 2024 Q4: 12,000 shares, $297K, <0.01% of portfolio
- 2025 Q1: 12,000 shares, $205K, <0.01% of portfolio
- 2025 Q2: 12,000 shares, $192K, <0.01% of portfolio
- 2025 Q3: 24,000 shares, $387K, <0.01% of portfolio, Add +100.0%
- 2025 Q4: 12,000 shares, $305K, <0.01% of portfolio, Reduce −50.0%
- 2026 Q1: 1,546,000 shares, $38M, 0.22% of portfolio, Add +12783.3%
- 2026 Q2: 5,805,000 shares, $224M, 1.0% of portfolio, Add +275.5%
- 2026 Q3: 6,471,000 shares, $219M, 0.94% of portfolio, Add +11.5%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|